ADT IRL.
This NCDB study found that 41% of men receiving radiation for intermediate risk prostate cancer received ADT–32% with favorable and 53%with unfavorable disease. | Agrawal, Adv Radiat Oncol 2022
With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
This NCDB study found that 41% of men receiving radiation for intermediate risk prostate cancer received ADT–32% with favorable and 53%with unfavorable disease. | Agrawal, Adv Radiat Oncol 2022
Comments
Post a Comment